MCC
PCRX icon

Malaga Cove Capital’s Pacira BioSciences PCRX Stock Holding History

Malaga Cove Capital’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-19,713
Closed -$750K – 161
2019
Q3 		$750K Sell
19,713
-1,658
-8% -$66.2K 0.51% 79
2019
Q2 		$929K Sell
21,371
-775
-3% -$32.9K 0.6% 59
2019
Q1 		$843K Hold
22,146
– – 0.52% 65
2018
Q4 		$924K Sell
22,146
-1,500
-6% -$70K 0.64% 46
2018
Q3 		$1.17M Buy
23,646
+764
+3% +$33K 0.63% 49
2018
Q2 		$733K Sell
22,882
-923
-4% -$31.9K 0.37% 87
2018
Q1 		$742K Buy
23,805
+3,118
+15% +$111K 0.4% 73
2017
Q4 		$944K Buy
20,687
+78
+0.4% +$3.09K 0.53% 61
2017
Q3 		$777K Buy
20,609
+12,877
+167% +$518K 0.45% 68
2017
Q2 		$373K Buy
+7,732
New +$359K 0.22% 92

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return